More importantly, the targeted enrichment of CSF1R and IL12 in glioblastoma blocked the CSF1‐CSF1R signaling axis to promote M2‐to‐M1 repolarization and activated the antitumor T cell responses, respectively, which expedited the execution of glioblastoma. The gene discussed is CSF1; the disease is glioblastoma.